Use of an intravascular thrombectomy device to treat life-threatening venous thrombosis in a patient with Crohn's disease and G20210A prothrombin gene mutation [3]

Inflammatory Bowel Diseases

Volumn 13, Issue 4, 2007, Pages 505-508

  Latzman, G S ^a   Kornbluth, A ^a   Murphy, S J ^a   Legnani, P ^a   George, J ^a   Guller, J ^a   Lewin, S ^a   Carroccio, A ^b   Harris, M T ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; HEPARIN; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MESALAZINE; PROTHROMBIN; PROTHROMBIN G20210A; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; WARFARIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANAMNESIS; CASE REPORT; COLON ANASTOMOSIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DEVICE; FEMALE; FEVER; GENE MUTATION; HEMATOCHEZIA; HUMAN; LAPAROSCOPY; LETTER; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RHEOLYTIC THROMBECTOMY; TACHYCARDIA;

ADULT; CROHN DISEASE; FEMALE; HUMANS; MESENTERIC VEINS; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN; REOPERATION; THROMBECTOMY; VENOUS THROMBOSIS;

EID: 34247592290     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20037     Document Type: Letter

References (14)

1. Koutroubakis IE. Therapy insight: vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(6):266-272.
2. Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med. 1936;58:17-31.
3. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61(2):140-145.
4. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost. 2001;85(3):430-434.
5. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99(1):97-101.
6. Fichera A, Cicchiello LA, Mendelson DS, et al. Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: A not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum. 2003;46(5):643-648.
7. Guedon C, Le Cam-Duchez V, Lalaude O, et al. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol. 2001;96(5):1448-1454.
8. Papa A, De Stefano V, Gasbarrini A, et al. Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis. 2000;11(5):499-503.
9. Rivitz SM, Geller SC, Hahn C, et al. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Interv Radiol. 1995;6(2):219;224-228.
10. Sze DY, O'Sullivan GJ, Johnson DL, et al. Mesenteric and portal venous thrombosis treated by transjugular mechanical thrombolysis. AJR Am J Roentgenol. 2000;175(3):732-734.
11. Morasch MD, Ebaugh JL, Chiou AC, et al. Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg. 2001;34(4):680-684.
12. Henao EA, Bohannon WT, Silva MB Jr. Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vase Surg. 2003;38(6):1411-1415.
13. Poplausky MR, Kaufman JA, Geller SC, et al. Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterology. 1996;110(5):1633-1635.
14. Tateishi A, Mitsui H, Oki T, et al. Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation. J Gastroenterol Hepatol. 2001;16(12):1429-1433.